Valley Forge, Pa. – Jonathan H. Spadt, a Shareholder with RatnerPrestia, along with James Gould of Schering-Plough, and David Shen of AstraZeneca, presented “Examining Patent Strategy in a Changing and Competitive Global Environment” at IQPC’s 2nd Patent Strategies for Pharma, Biotech and Medical Device Industries Conference.  Held at The Ritz Carlton in Philadelphia on July 16, 2008, the conference brought industry leaders together to debate pressing market issues.  Attendees were given the   opportunity to hear from in-house experts, experienced outside counsel, judges and government officials on best practices regarding the myriad of issues in contemporary IP. 

 

In its third decade, RatnerPrestia is one of the largest intellectual property law firms in the Mid-Atlantic  region.  Its clients range from start-up companies to multi-billion dollar corporations, both domestic and international, and from private individuals to well-known institutions and universities.  For more information, call (610) 407-0700.